Skip to main content

Everolimus/exemestane improves PFS of ER+/HER2– breast cancer vs. everolimus alone

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Everolimus/exemestane improves PFS of ER+/HER2– breast cancer vs. everolimus alone

User login

Username

Password

Reset your password

Type	Lead	score